Semaglutide vs Syn-Ake

A detailed comparison to help you understand the differences and choose the right peptide for your research goals.

Semaglutide

Semaglutide is a GLP-1 receptor agonist that has revolutionized weight management and diabetes treatment. FDA-approved as Ozempic (diabetes), Wegovy (weight loss), and Rybelsus (oral form), it has become one of the most prescribed peptides worldwide.

Full details →

Syn-Ake

Syn-Ake (Dipeptide Diaminobutyroyl Benzylamide Diacetate) is a synthetic tripeptide that mimics the effect of Waglerin-1, a peptide found in Temple Viper venom. It's used in cosmetics for anti-wrinkle effects.

Full details →

Side-by-Side Comparison

AspectSemaglutideSyn-Ake
MechanismMimics glucagon-like peptide-1 (GLP-1) to stimulate insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite through hypothalamic signaling. The result is significant reduction in food intake and improved glycemic control.Acts as a competitive antagonist at the nicotinic acetylcholine receptor, reducing muscle contractions similar to Botox but through a different mechanism. Provides muscle-relaxing effects when applied topically.
Typical DosageWegovy (weight loss): Start at 0.25mg weekly, titrate up to 2.4mg weekly over 16-20 weeks. Ozempic (diabetes): 0.25mg to 1mg weekly. Research protocols vary.Topical: 1-4% concentration in serums or creams. Applied 1-2 times daily to target areas like forehead and crow's feet.
AdministrationSubcutaneous injection once weekly, typically in abdomen, thigh, or upper arm. Rybelsus is taken orally on empty stomach. Dose titration is essential to minimize GI side effects.Topical application only. Should be applied to clean skin. Often combined with other anti-aging peptides for synergistic effects.
Side EffectsCommon: nausea, vomiting, diarrhea, constipation, abdominal pain. These typically decrease over time. May cause injection site reactions.Generally well-tolerated topically. Rare reports of mild skin irritation or sensitivity.
Best For

Key Differences

Unique to Semaglutide:

Unique to Syn-Ake:

Ready to Learn More?